Abstract
Treatment of metastatic melanoma with autologous tumor infiltrating lymphocytes (TILs) is currently applied in several centers. Robust and remarkably consistent overall response rates, of around 50% of treated patients, have...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have